Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03194828 · ClinicalTrials.gov registry record · NA
Real-time Glaucoma Medication Adherence
A NA study, sponsored by University of Tennessee.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03194828 is a NA study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 5 participants.
The verdict
NCT03194828, a NA study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receive on-demand reminder messages, when necessary.
Interventions
- BEHAVIORAL Medication reminder
- BEHAVIORAL Medication monitoring only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2018-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03194828
The ClinicalTrials.gov registry entry for NCT03194828 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medication reminder is the first listed.
NCT03194828 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03194828 about?
NCT03194828 is a clinical study titled "Real-time Glaucoma Medication Adherence". This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receiv...
What is the current status of trial NCT03194828?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-05-08. Estimated completion is 2018-07-15.
What interventions are being tested in trial NCT03194828?
The interventions under investigation include: Medication reminder (BEHAVIORAL), Medication monitoring only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03194828?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.